Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial comparing Urtica comp. gel (Swissmedic listed medication in the
category of "Anthroposophic Medication without Indication") against standard skin care,
examining its effect in prevention and treatment of radiation dermatitis in breast cancer
patients under Radiation therapy.